AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9434700 — intervention group
Group type: EXPERIMENTAL
Intervention: Group PN (19 patients) received glucose and crystalloid amino acid solution at a dosage of 0.8 +/- 0.1 gm/kg per day
Number of subjects: 37
Study 9434700 — intervention group
Group type: COMPARATOR
Intervention: Group STANDARD (18 patients) received glucose as the maintenance fluid
Number of subjects: 37
Study 9434700 — intervention group
Group type: COMPARATOR
Intervention: Group STANDARD
Number of subjects: 37
Study 9434700 — intervention group
Group type: EXPERIMENTAL
Intervention: Group PN
Number of subjects: 37
Study 9434700 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 37
Study 9434700 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 37
Study 7880661 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac 75 mg i.m. injection 1-2 h before operation
Number of subjects: 40
Study 7880661 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac 75 mg i.m. immediately after surgery
Number of subjects: 40
Study 3069749 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine
Number of subjects: 0
Study 3069749 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine
Number of subjects: 0
Study 3069749 — intervention group
Group type: COMPARATOR
Intervention: Scopolamine
Number of subjects: 0
Study 3069749 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 0
Study 29139320 — intervention group
Group type: EXPERIMENTAL
Intervention: Cable news watching (Fox News and MSNBC)
Number of subjects: 34
Study 29139320 — intervention group
Group type: COMPARATOR
Intervention: Negative control (Public Broadcasting Station)
Number of subjects: 34
Study 29139320 — intervention group
Group type: COMPARATOR
Intervention: Positive control (Trier social stress test)
Number of subjects: 34
Study 28263765 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal testosterone (50mg)
Number of subjects: 82
Study 28263765 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 28263765 — intervention group
Group type: COMPARATOR
Intervention: Comparison between testosterone and placebo groups
Number of subjects: 82
Study 26161483 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based blood pressure monitor (CBPM)
Number of subjects: 50
Study 26161483 — intervention group
Group type: COMPARATOR
Intervention: Validated automatic blood pressure monitor (ABPM)
Number of subjects: 50
Study 23637214 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume-rendered images derived from intraoperative cone-beam computed tomography imaging
Number of subjects: 24
Study 23637214 — intervention group
Group type: COMPARATOR
Intervention: Conventional fluoroscopic C-arm
Number of subjects: 24
Study 22942521 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-role practitioners
Number of subjects: 58
Study 22942521 — intervention group
Group type: COMPARATOR
Intervention: Experienced therapists
Number of subjects: 58
Study 18469247 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated coffee (5 mg/kg) with high glycemic index meal
Number of subjects: 10
Study 18469247 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated coffee (5 mg/kg) with low glycemic index meal
Number of subjects: 10
Study 16520564 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep breathing exercises with Incentive Spirometer
Number of subjects: 34
Study 16520564 — intervention group
Group type: COMPARATOR
Intervention: Deep breathing exercise without Incentive Spirometer
Number of subjects: 34
Study 12853868 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 199
Study 12853868 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived health functioning
Number of subjects: 199
Study 10812390 — intervention group
Group type: EXPERIMENTAL
Intervention: Smectite (2 x 6 g daily)
Number of subjects: 176
Study 10812390 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 x 6 g daily)
Number of subjects: 176
Study 10812390 — intervention group
Group type: EXPERIMENTAL
Intervention: Smectite (2 x 6 g daily) in subgroup with small bowel volume <= 837.5 ml
Number of subjects: 176
Study 10812390 — intervention group
Group type: COMPARATOR
Intervention: Placebo in subgroup with small bowel volume <= 837.5 ml
Number of subjects: 176
Study 10812390 — intervention group
Group type: EXPERIMENTAL
Intervention: Smectite (2 x 6 g daily) in subgroup with small bowel volume > 837.5 ml
Number of subjects: 176
Study 10812390 — intervention group
Group type: COMPARATOR
Intervention: Placebo in subgroup with small bowel volume > 837.5 ml
Number of subjects: 176
Study 8984754 — intervention group
Group type: EXPERIMENTAL
Intervention: Operation and walking-cast
Number of subjects: 79
Study 8984754 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking-cast alone
Number of subjects: 79
Study 8984754 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic bandage
Number of subjects: 79
Study 8984754 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 79
Study 1452528 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP)
Number of subjects: 25
Study 1452528 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpromazine (CPZ)
Number of subjects: 25
Study 6137021 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (300 mg every 6 h) with alprazolam (1.0 mg)
Number of subjects: 0
Study 6137021 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (300 mg every 6 h) with triazolam (0.5 mg)
Number of subjects: 0
Study 30823878 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching Basic Life Support (case group)
Number of subjects: 92
Study 30823878 — intervention group
Group type: COMPARATOR
Intervention: Control group (no teaching)
Number of subjects: 92
Study 30823878 — intervention group
Group type: EXPERIMENTAL
Intervention: Training of community health professionals
Number of subjects: 92
Study 29983350 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg adalimumab
Number of subjects: 28
Study 29983350 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 26780167 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic sacrocolpopexy
Number of subjects: 200
Study 26780167 — intervention group
Group type: COMPARATOR
Intervention: Abdominal sacrocolpopexy
Number of subjects: 200
Study 24429400 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol anesthesia
Number of subjects: 112
Study 24429400 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane anesthesia
Number of subjects: 112
Study 21812672 — intervention group
Group type: EXPERIMENTAL
Intervention: Horse ATG
Number of subjects: 120
Study 21812672 — intervention group
Group type: COMPARATOR
Intervention: Rabbit ATG
Number of subjects: 120
Study 19702711 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg intravitreal triamcinolone acetonide (ivTA)
Number of subjects: 107
Study 19702711 — intervention group
Group type: COMPARATOR
Intervention: 4 mg triamcinolone alone
Number of subjects: 107
Study 19702711 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg triamcinolone plus sequential laser
Number of subjects: 107
Study 16749588 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 50 mg/day (Group B)
Number of subjects: 150
Study 16749588 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 50 mg/day and potassium citrate 20 mlEq/day (Group C)
Number of subjects: 150
Study 16749588 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group A)
Number of subjects: 150
Study 15310446 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar epidural blockade with bupivacaine 0.25% (10 mg bolus and 5 mg/h continuous infusion)
Number of subjects: 24
Study 15310446 — intervention group
Group type: COMPARATOR
Intervention: Customary antihypertensive treatment
Number of subjects: 24
Study 11181756 — intervention group
Group type: EXPERIMENTAL
Intervention: LIPC promoter polymorphism
Number of subjects: 578
Study 9709283 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammographic screening
Number of subjects: 3
Study 7690729 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Magara technique
Number of subjects: 84
Study 7690729 — intervention group
Group type: COMPARATOR
Intervention: Meigs technique
Number of subjects: 84
Study 7690729 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 84
Study 2424239 — intervention group
Group type: EXPERIMENTAL
Intervention: Arotinoid Ro 13‐6298
Number of subjects: 30
Study 2424239 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotretinoin
Number of subjects: 30
Study 2424239 — intervention group
Group type: COMPARATOR
Intervention: Etretin
Number of subjects: 30
Study 1100294 — intervention group
Group type: EXPERIMENTAL
Intervention: Lirutrin (measles‐mumps‐rubella live, attenuated virus vaccine)
Number of subjects: 273
Study 1100294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 273
Study 31399456 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based multicomponent intervention combined with individualised clinical facilitator led support
Number of subjects: 0
Study 31399456 — intervention group
Group type: COMPARATOR
Intervention: Self-help booklet and relaxation compact disc
Number of subjects: 0
Study 28295912 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic exercise (balance exercise assist robot)
Number of subjects: 27
Study 28295912 — intervention group
Group type: COMPARATOR
Intervention: Conventional balance training
Number of subjects: 27
Study 25394681 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA and zinc-enriched supplementation (6,400 mg/day BCAAs and 10 mg/day zinc)
Number of subjects: 53
Study 25394681 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 25394681 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA and zinc-enriched supplementation
Number of subjects: 53
Study 23771586 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist path analysis during spatial pointing movements
Number of subjects: 0
Study 23771586 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist speed profiles
Number of subjects: 0
Study 22134452 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD numbing and hyperarousal symptom clusters
Number of subjects: 943
Study 22134452 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD symptom clusters
Number of subjects: 943
Study 18534406 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital radiographs for assessing postoperative component SSA
Number of subjects: 15
Study 18534406 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital radiographs for assessing preoperative NSA
Number of subjects: 15
Study 18534406 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic femur positioned in 10 degrees increments of either flexion or rotation
Number of subjects: 15
Study 17456482 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin (ENOX)
Number of subjects: 20479
Study 17456482 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 20479
Study 14990643 — intervention group
Group type: EXPERIMENTAL
Intervention: CTRT (pelvic radiotherapy with concomitant fluorouracil and cisplatin)
Number of subjects: 403
Study 14990643 — intervention group
Group type: COMPARATOR
Intervention: EFRT (extended-field radiotherapy)
Number of subjects: 403
Study 14990643 — intervention group
Group type: EXPERIMENTAL
Intervention: CTRT
Number of subjects: 403
Study 11843231 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapalene gel 0.1%
Number of subjects: 150
Study 11843231 — intervention group
Group type: COMPARATOR
Intervention: Tretinoin gel 0.025%
Number of subjects: 150
Study 8988956 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol (5.0 mg b.i.d. or 2.5 mg t.i.d.)
Number of subjects: 43
Study 8988956 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 8988956 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 43
Study 8988956 — intervention group
Group type: COMPARATOR
Intervention: Pindolol and Placebo
Number of subjects: 43
Study 8237986 — intervention group
Group type: EXPERIMENTAL
Intervention: Monetary incentive (10 Swiss francs) and reminder card
Number of subjects: 1235
Study 8237986 — intervention group
Group type: EXPERIMENTAL
Intervention: Monetary incentive only
Number of subjects: 1235
Study 8237986 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder card only
Number of subjects: 1235
Study 8237986 — intervention group
Group type: COMPARATOR
Intervention: No incentive
Number of subjects: 1235
Study 8237986 — intervention group
Group type: EXPERIMENTAL
Intervention: Both incentives in follow-up mailings
Number of subjects: 1235
Study 3655634 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet group (carbohydrate restriction to 120 g daily)
Number of subjects: 0
Study 3655634 — intervention group
Group type: COMPARATOR
Intervention: No diet group (limit use of table sugar)
Number of subjects: 0
Study 31915086 — intervention group
Group type: EXPERIMENTAL
Intervention: Unhealthy food branding
Number of subjects: 1331
Study 31915086 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthier food branding
Number of subjects: 1331
Study 31915086 — intervention group
Group type: EXPERIMENTAL
Intervention: Public health nutrition campaign branding
Number of subjects: 1331
Study 31915086 — intervention group
Group type: COMPARATOR
Intervention: Non-food branding (control)
Number of subjects: 1331
Study 29891524 — intervention group
Group type: EXPERIMENTAL
Intervention: Early initiation of salvage androgen deprivation therapy (ADT) for post-radiation therapy PSA failure in men with PSA doubling time (PSA-DT) ≥6 months.
Number of subjects: 54
Study 29891524 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing PSA-DT as a continuous covariate (per month increase).
Number of subjects: 54
Study 29891524 — intervention group
Group type: EXPERIMENTAL
Intervention: Short PSA-DT (<6 months) with salvage ADT initiation.
Number of subjects: 54
Study 27627802 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular repair
Number of subjects: 881
Study 27627802 — intervention group
Group type: COMPARATOR
Intervention: Open repair
Number of subjects: 881
Study 24301456 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Number of subjects: 380
Study 24301456 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil/folinic acid
Number of subjects: 380
Study 24301456 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine with low hENT1 expression
Number of subjects: 380
Study 24301456 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine with high hENT1 expression
Number of subjects: 380
Study 24301456 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil with low hENT1 expression
Number of subjects: 380
Study 24301456 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil with high hENT1 expression
Number of subjects: 380
Study 24301456 — intervention group
Group type: COMPARATOR
Intervention: Observation group
Number of subjects: 380
Study 23566058 — intervention group
Group type: EXPERIMENTAL
Intervention: Oligonol (100 mg)
Number of subjects: 17
Study 23566058 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 17
Study 19669856 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser phototherapy (one session per week for 10 weeks, 780 nm, 60 mW, 3.0 J/cm² or 4.5 J/cm²)
Number of subjects: 71
Study 19669856 — intervention group
Group type: COMPARATOR
Intervention: Topical aciclovir treatment (control group)
Number of subjects: 71
Study 18684176 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Observed Therapy (DOT)
Number of subjects: 48
Study 18684176 — intervention group
Group type: COMPARATOR
Intervention: Self-Administration (SA)
Number of subjects: 48
Study 17127546 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil 400 mg
Number of subjects: 12
Study 17127546 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil 800 mg
Number of subjects: 12
Study 17127546 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 12
Study 17127546 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg IV cocaine
Number of subjects: 12
Study 17127546 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg IV cocaine
Number of subjects: 12
Study 14661072 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomic Benoist Girard (ABG) femoral stem
Number of subjects: 60
Study 14661072 — intervention group
Group type: COMPARATOR
Intervention: Mallory‐Head (MH) femoral stem
Number of subjects: 60
Study 10950408 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser photocoagulation therapy
Number of subjects: 0
Study 10950408 — intervention group
Group type: COMPARATOR
Intervention: Natural course of the disease
Number of subjects: 0
Study 9055771 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time ultrasound-guided catheterization
Number of subjects: 20
Study 9055771 — intervention group
Group type: COMPARATOR
Intervention: Standard landmark-oriented approach
Number of subjects: 20
Study 8373604 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental 5 mg/kg
Number of subjects: 90
Study 8373604 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 2.4 mg/kg
Number of subjects: 90
Study 8373604 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.3 mg/kg
Number of subjects: 90
Study 2938518 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.14 mg/kg of midazolam (midazolam hydrochloride 5 mg/ml)
Number of subjects: 50
Study 2938518 — intervention group
Group type: COMPARATOR
Intervention: 0.29 mg/kg diazepam (Valium 5 mg/ml)
Number of subjects: 50
Study 31567817 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-VEGF therapy
Number of subjects: 883
Study 31567817 — intervention group
Group type: COMPARATOR
Intervention: Laser photocoagulation, sham, or intravitreal saline (Control)
Number of subjects: 883
Study 28272105 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher optical quality polish of prosthesis
Number of subjects: 41
Study 28272105 — intervention group
Group type: COMPARATOR
Intervention: Standard polish of prosthesis
Number of subjects: 41
Study 27309887 — intervention group
Group type: EXPERIMENTAL
Intervention: binimetinib
Number of subjects: 51
Study 24965052 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist average alliance score
Number of subjects: 158
Study 24965052 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist experience conducting couple therapy
Number of subjects: 158
Study 24965052 — intervention group
Group type: COMPARATOR
Intervention: Therapist gender
Number of subjects: 158
Study 24965052 — intervention group
Group type: COMPARATOR
Intervention: Therapist discipline
Number of subjects: 158
Study 24965052 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist average alliance score and experience
Number of subjects: 158
Study 22965591 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab with prompt laser treatment
Number of subjects: 361
Study 22965591 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab with deferred laser treatment
Number of subjects: 361
Study 22965591 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab
Number of subjects: 361
Study 20537319 — intervention group
Group type: EXPERIMENTAL
Intervention: Indicated cognitive‐behavioral depression prevention program
Number of subjects: 300
Study 20537319 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only controls
Number of subjects: 300
Study 18502245 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy for depression
Number of subjects: 24
Study 17092253 — intervention group
Group type: EXPERIMENTAL
Intervention: RR/RH genotypes of FcgammaRIIa in SLE patients
Number of subjects: 195
Study 17092253 — intervention group
Group type: EXPERIMENTAL
Intervention: RR/RH genotypes of FcgammaRIIa and ACC/ACC haplotype of IL‐10
Number of subjects: 195
Study 17092253 — intervention group
Group type: EXPERIMENTAL
Intervention: FcgammaRIIa, RR homozygotes
Number of subjects: 195
Study 12783149 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-loop responses starting from A at the right endpoint of the segment
Number of subjects: 0
Study 12783149 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop responses from A at the right endpoint of the segment
Number of subjects: 0
Study 12783149 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-loop responses from A at the left endpoint of the segment
Number of subjects: 0
Study 12783149 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-loop responses from A aligned horizontally with the left endpoint of the segment but displaced vertically below that segment
Number of subjects: 0
Study 10085542 — intervention group
Group type: EXPERIMENTAL
Intervention: Jorvik museum odours
Number of subjects: 3
Study 10085542 — intervention group
Group type: COMPARATOR
Intervention: Control odours
Number of subjects: 3
Study 10085542 — intervention group
Group type: COMPARATOR
Intervention: No odours
Number of subjects: 3
Study 10162148 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors (ACE-Is)
Number of subjects: 100
Study 10162148 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 100
Study 10162148 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 100
Study 10162148 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE-Is for patients with ejection fraction ≤ 40%
Number of subjects: 100
Study 10162148 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE-Is for patients with ejection fraction > 40%
Number of subjects: 100
Study 10162148 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium channel blockers
Number of subjects: 100
Study 10162148 — intervention group
Group type: COMPARATOR
Intervention: Documentation of left ventricular function
Number of subjects: 100
Study 10162148 — intervention group
Group type: COMPARATOR
Intervention: Use of ACE-Is for patients with ejection fraction ≤ 40%
Number of subjects: 100
Study 10162148 — intervention group
Group type: COMPARATOR
Intervention: Use of calcium channel blockers and beta blockers
Number of subjects: 100
Study 2058666 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine phosphate, 250 mg four times daily for 3 days
Number of subjects: 20
Study 6651284 — intervention group
Group type: EXPERIMENTAL
Intervention: azlocillin
Number of subjects: 20
Study 6651284 — intervention group
Group type: COMPARATOR
Intervention: Control (no azlocillin)
Number of subjects: 20
Study 30903962 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 60